NTN1 and neoplasm: discovered that NTN1 interference limits tumour resistance to immune checkpoint inhibitors and provided evidence linking this enhanced anti‐tumour efficacy to a decreased recruitment of a subtype of MDSCs called polymorphonuclear (PMN)‐MDSCs.